Skip to content

Bio-Techne TECH Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin64.8%-1.6pp66.4%-1.3pp67.7%-0.7pp68.4%
Efficiency
Asset turnover0.5×0.0×0.4×0.0×0.5×0.0×0.5×
Liquidity
Current ratio3.5×-0.4×3.9×-1.0×4.8×+1.4×3.4×+0.1×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×-0.1×
Per Share
Book value per share$12.01-6.6%$12.87+5.9%$12.15+17.2%$10.37+7.4%
Valuation
Market capitalization$7.84B-30.5%$11.27B-12.7%$12.91B-5.1%$13.6B-23.1%
Price / sales6.4×-3.3×9.7×-1.6×11.4×-0.9×12.3×-6.7×
Price / book4.1×-1.4×5.4×-1.1×6.6×-1.4×-3.3×
Dividend yield0.6%+0.2pp0.4%+0.1pp0.4%0.0pp0.4%+0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bio-Techne's profit margins?
Bio-Techne (TECH) runs a 65.0% gross margin and a 14.2% operating margin, with a 10.9% net margin.
Where do Bio-Techne's ratios come from?
Every ratio is computed from Bio-Techne's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.